Note 12 - Financial Instruments - Summary of Effect of Designated Derivative Financial Instruments on Consolidated Financial Statements (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Cost of sales	$ 2,254	$ 2,169	$ 6,538	$ 6,574
Other Nonoperating Income (Expense)	(166)	33	(59)	128
Gain (loss) recognized in other comprehensive income	(68)	28	(59)	102
Net income of reportable segments	(117)	164	196	621
Reclassification out of Accumulated Other Comprehensive Income [Member]
Cost of sales	15	14	36	32
Other Nonoperating Income (Expense)		(1)	(1)	(3)
Net income of reportable segments	15	13	35	29
Foreign Exchange Contract [Member]
Cost of sales	$ (68)	$ 28	$ (59)	$ 102